SphK1 inactivation by PQR620 appeared to be mTOR-independent, as Akt1/2 shRNA and AZD-2014 failed to inhibit SphK1 activation in NSCLC cells. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.